-
AbbVie Inc. v. Hospira Inc. DC CAFC
- 1:11-cv-00648
- D. Del.
- Judge: Gregory M. Sleet
- Filed: 07/21/2011
- Closed: 10/24/2014
- Latest Docket Entry: 02/06/2015
- PACER
- Docket updated daily
1
Plaintiff
1
Defendant
1
Accused
Product
2
Patents-in-Suit
1,192
Days in
Litigation
-
AbbVie Inc. v. Hospira Inc. DC CAFC
- 1:11-cv-00648
- D. Del.
- Judge: Gregory M. Sleet
- Filed: 07/21/2011
- Closed: 10/24/2014
- Latest Docket Entry: 02/06/2015
- PACER
- Docket updated daily
Market Sector
Biotech and Pharma
Court
Assigned Judge
Outcome Summary
- Patent Information
-
Validity & Enforceability
| Claim | Outcome |
|---|---|
| All challenged claims |
Valid (103)
Entry 200 |
| Claim # | Claim Text | Outcome |
|---|---|---|
| 7 |
The composition of claim 6 wherein the vitamin D compound is paracalcitol or calcitriol.
|
Valid (103)
Entry 201 |
| 8 |
The composition of claim 7 wherein the vitamin D compound is present between about 2 .mu.g/ml and about 10 .mu.g/ml.
|
Valid (103)
Entry 201 |
| 9 |
The composition of claim 8 wherein the vitamin D compound is present at about 5 .mu.g/ml.
|
Valid (103)
Entry 201 |
-
Infringement
Hospira Incorporated
- 1 Detail
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| paricalcitol injectable drugParicalcitol injectable drug products in 2 mcg/ml, 5 mcg/ml, and 10 mcg/2 ml (5 mcg/ml) formulations | US 6,136,799 A |
7, 8, 9
|
No infringement
Entry 200Entry 201 |
